Sei Investments Co. Grows Position in The Clorox Company (NYSE:CLX)

Sei Investments Co. boosted its position in The Clorox Company (NYSE:CLX) by 28.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 98,794 shares of the company’s stock after purchasing an additional 21,970 shares during the quarter. Sei Investments Co. owned approximately 0.08% of Clorox worth $16,045,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brooklyn Investment Group increased its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Continuum Advisory LLC increased its stake in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Millstone Evans Group LLC purchased a new position in shares of Clorox during the fourth quarter valued at approximately $31,000. Asset Planning Inc bought a new stake in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Clorox in the 4th quarter worth approximately $36,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.4 %

Shares of NYSE:CLX opened at $146.18 on Friday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The stock has a market capitalization of $18.01 billion, a price-to-earnings ratio of 39.94, a PEG ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock’s 50-day simple moving average is $151.34 and its two-hundred day simple moving average is $159.09.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the business earned $2.16 earnings per share. Analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.34%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CLX shares. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company increased their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Barclays decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a report on Thursday. Finally, Evercore ISI increased their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus price target of $159.50.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.